Athira Pharma
Bothell, WA
Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.
athira.comCompany Details
Founded
- 2011
Employees
- Between 19 - 100 employees
Raised
- $323,600,000
Headquarters Location
- Bothell, WA
Public
- Yes
Acquired
- No
CEO
Mark Litton
Founders
- Joseph HardingLeen KawasLewis Rumpler
Company Collections
These are collections Athira Pharma is a part of. Click on the collection name to view similar companies.
Athira Pharma Headquarters Location
Total Amount Raised: $323,600,000
Athira Pharma Funding Rounds
Post Ipo Equity
$90,000,000
Post Ipo Equity
$103,500,000
Grant
$15,000,000
Series B
$85,000,000
IPO
Unknown
Series B
$15,200,000
Series Unknown
$1,400,000
Series A
$10,000,000
Series Unknown
$3,500,000
Athira Pharma Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Athira Pharma.